Literature DB >> 27429712

Beyond Statistics: The Economic Content of Risk Scores.

Liran Einav1, Amy Finkelstein2, Raymond Kluender3, Paul Schrimpf4.   

Abstract

"Big data" and statistical techniques to score potential transactions have transformed insurance and credit markets. In this paper, we observe that these widely-used statistical scores summarize a much richer heterogeneity, and may be endogenous to the context in which they get applied. We demonstrate this point empirically using data from Medicare Part D, showing that risk scores confound underlying health and endogenous spending response to insurance. We then illustrate theoretically that when individuals have heterogeneous behavioral responses to contracts, strategic incentives for cream skimming can still exist, even in the presence of "perfect" risk scoring under a given contract.

Entities:  

Year:  2016        PMID: 27429712      PMCID: PMC4945120          DOI: 10.1257/app.20150131

Source DB:  PubMed          Journal:  Am Econ J Appl Econ        ISSN: 1945-7790


  9 in total

1.  Policy watch: Medicare.

Authors:  J P Newhouse
Journal:  J Econ Perspect       Date:  1996

2.  The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.

Authors:  Mark Duggan; Fiona Scott Morton
Journal:  Am Econ Rev       Date:  2010-03

3.  How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program.

Authors:  Jason Brown; Mark Duggan; Ilyana Kuziemko; William Woolston
Journal:  Am Econ Rev       Date:  2014-10

4.  How Do Hospitals Respond to Price Changes?

Authors:  Leemore S Dafny
Journal:  Am Econ Rev       Date:  2005-12

5.  Regional variations in diagnostic practices.

Authors:  Yunjie Song; Jonathan Skinner; Julie Bynum; Jason Sutherland; John E Wennberg; Elliott S Fisher
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

6.  Steps to reduce favorable risk selection in medicare advantage largely succeeded, boding well for health insurance exchanges.

Authors:  Joseph P Newhouse; Mary Price; Jie Huang; J Michael McWilliams; John Hsu
Journal:  Health Aff (Millwood)       Date:  2012-12       Impact factor: 6.301

7.  Selection on Moral Hazard in Health Insurance.

Authors:  Liran Einav; Amy Finkelstein; Stephen Ryan; Paul Schrimpf; Mark R Cullen
Journal:  Am Econ Rev       Date:  2013-02

8.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

9.  Digesting the doughnut hole.

Authors:  Geoffrey F Joyce; Julie Zissimopoulos; Dana P Goldman
Journal:  J Health Econ       Date:  2013-05-06       Impact factor: 3.883

  9 in total
  5 in total

1.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

2.  VOLUNTARY REGULATION: EVIDENCE FROM MEDICARE PAYMENT REFORM.

Authors:  Liran Einav; Amy Finkelstein; Yunan Ji; Neale Mahoney
Journal:  Q J Econ       Date:  2021-09-20

3.  Upcoding: Evidence from Medicare on Squishy Risk Adjustment.

Authors:  Michael Geruso; Timothy Layton
Journal:  J Polit Econ       Date:  2020-01-29

4.  Predicting later life health status and mortality using state-level socioeconomic characteristics in early life.

Authors:  Rita Hamad; David H Rehkopf; Kai Y Kuan; Mark R Cullen
Journal:  SSM Popul Health       Date:  2016-12

Review 5.  Aligning policy objectives and payment design in palliative care.

Authors:  Stephen Duckett
Journal:  BMC Palliat Care       Date:  2018-03-07       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.